A Cross-Reactive Monoclonal Antibody to Nematode Haemoglobin Enhances Protective Immune Responses to Nippostrongylus brasiliensis

• Natalie E. Nieuwenhuizen ,

  * E-mail: nnieuwen@gmail.com

  Current address: Department of Immunology, Max-Planck-Institut für Infektionsbiologie, Campus Charité Mitte, Berlin, Germany.

  Affiliation International Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, and Institute of Infectious Diseases and Molecular Medicine (IIDMM) and Medical Research Council, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town, South Africa

  ⨯
• Jeanne M. Meter,

  Affiliation International Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, and Institute of Infectious Diseases and Molecular Medicine (IIDMM) and Medical Research Council, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town, South Africa

  ⨯
• William G. Horsnell,

  Affiliation International Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, and Institute of Infectious Diseases and Molecular Medicine (IIDMM) and Medical Research Council, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town, South Africa

  ⨯
• J. Claire Hoving,

  Affiliation International Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, and Institute of Infectious Diseases and Molecular Medicine (IIDMM) and Medical Research Council, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town, South Africa

  ⨯
• Lizette Fick,

  Affiliation International Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, and Institute of Infectious Diseases and Molecular Medicine (IIDMM) and Medical Research Council, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town, South Africa

  ⨯
• Michael F. Sharp,

  Affiliation School of Pharmacy and Molecular Science, Centre for Biodiscovery and Molecular Development of Therapeutics, James Cook University, Townsville, Queensland, Australia

  ⨯
• Matthew G. Darby,

  Affiliation International Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, and Institute of Infectious Diseases and Molecular Medicine (IIDMM) and Medical Research Council, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town, South Africa

  ⨯
• Suraj P. Parihar,

  Affiliation International Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, and Institute of Infectious Diseases and Molecular Medicine (IIDMM) and Medical Research Council, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town, South Africa

  ⨯
• Frank Brombacher,

  Affiliation International Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, and Institute of Infectious Diseases and Molecular Medicine (IIDMM) and Medical Research Council, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town, South Africa

  ⨯
• Andreas L. Lopata

  Affiliations International Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, and Institute of Infectious Diseases and Molecular Medicine (IIDMM) and Medical Research Council, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town, South Africa, School of Pharmacy and Molecular Science, Centre for Biodiscovery and Molecular Development of Therapeutics, James Cook University, Townsville, Queensland, Australia

  ⨯